ACADIA Pharmaceuticals ( ACAD ) is a commercial-stage biopharmaceutical company focused on addressing neurological and rare diseases. Its portfolio is currently composed of two commercial drugs: NUPLAZID for the treatment of positive symptoms occurring in Parkinson'sAt ELAM1, we empower financial professionals and investors with the scientific and clinical expertise required to navigate the complexities of the healthcare sector. By bridging the gap between cutting-edge science and financial strategy, we hel ...